Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 420
Selected: 0
NCT IDTitle
NCT00002895Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
NCT01538381Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck
NCT03260712Pembrolizumab in Biliary Tract Cancer
NCT00004886MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
NCT03784066Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
NCT00410462Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
NCT03755856Long-term Outcomes for Acute Myeloid Leukemia Patients
NCT05724602Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT00004099Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00052312Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
NCT02504372Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)
NCT00006351SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
NCT00006357STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
NCT00003061Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma
NCT02982694Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
NCT05270044Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
NCT00005584Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT01910376Cancer in Nursing Home Residents
NCT00028691Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma
NCT05974774Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
NCT00014586Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
NCT01658527TAK-700 in Castration Resistant Prostate Cancer
NCT01880359AF CRT +/- Nimorazole in HNSCC
NCT01705561Evaluation of Attitudes About Fertility
NCT03134118Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
NCT01652261Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
NCT04270123An EORTC Study Updating the QLQ-BR23 to BR45
NCT00498953Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
NCT00003982MEN-10755 in Treating Patients With Solid Tumors
NCT00003304Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
NCT01288378Empirical Versus Preemptive Antifungal Therapy
NCT00103168Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
NCT00014625E7070 in Treating Patients With Stage IV Melanoma
NCT02659384Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
NCT03470350Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
NCT04097093Long-term Surival of GIST Patients ≥ 10 Years on Imatinib
NCT00005868Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
NCT00002462RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
NCT04796454Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
NCT00646659Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
NCT03088059Biomarker-based Study in R/M SCCHN
NCT03357224PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)
NCT00003159Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
NCT00004151Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT05209529Chemo-free BRCA-targeted Neoadjuvant Strategy
NCT01924819Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
NCT02051868International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
NCT06347185Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study
NCT00004934Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
NCT04780464A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma